Eric Topol April 28, 2024

What happens when big advances in life science converge with A.I.

Aviv Regev is one of the leading life scientists of our time. In this conversation, we cover the ongoing revolution in digital biology that has been enabled by new deep knowledge on cells, proteins and genes, and the use of generative A.I .

Transcript with audio and external links

Eric Topol (00:05):

Hello, it’s Eric Topol with Ground Truths and with me today I’ve really got the pleasure of welcoming Aviv Regev, who is the Executive Vice President of Research and Early Development at Genentech, having been 14 years a leader at the Broad Institute and who I view as one of the leading life scientists in the world....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Conferences / Podcast, Pharma / Biotech, Technology, Trends
AbbVie takes option on Gilgamesh psychedelics in $2bn deal
Opinion: Cutting-edge insulin is good. But it’s the ‘trailing edge’ of older versions that can keep it affordable
Merck KGaA, Caris Sign Potential $1.4B Deal to Develop First-in-Class ADCs for Cancer
Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised
Leveraging Lessons from Commercialization and Distribution of Rare Products for Cell and Gene Therapy

Share This Article